Cytion specializes in providing a vast repository of over 1,300 authenticated human and animal cell lines, ensuring high-level reproducibility in biomedical research. Their portfolio features specialized models, including cancer cell lines, stem cells, and primary cells, all verified via rigorous STR profiling and mycoplasma testing. This comprehensive range is designed to meet the strict standards required for drug development and academic discovery across the globe.

The CELLBANKER® series, manufactured by Zenogen Pharma, provides a comprehensive range of ready-to-use cryopreservation media designed for high cell viability and recovery. Their portfolio includes specialized formulations like CELLBANKER 1 for general mammalian cells and the serum-free CELLBANKER 2 for protein-free applications. For advanced research and clinical use, the STEM-CELLBANKER® line offers GMP-compliant, chemically defined solutions optimized for stem cells, iPS cells, and organoids. A key advantage of the series is the ability to freeze cells directly at -80°C, eliminating the need for expensive programmable freezers or complex cooling protocols. These products are rigorously tested for sterility and mycoplasma to ensure reliable, long-term storage across diverse laboratory workflows.

Applied Biological Materials (abm) offers an extensive cell culture portfolio recognized for its focus on innovation and accessibility. Their catalog is anchored by the world’s largest collection of immortalized cell lines, providing researchers with an unparalleled selection of stable models for long-term studies. This diverse repository includes over 400 immortalized lines and 400 primary cell types spanning a wide range of animal species, including human, mouse, rat, porcine, and bovine.

Procell Life Science & Technology (Procell) offers a comprehensive cell culture portfolio specialized in the development of ready-to-use solutions and primary cell systems. Their catalog is distinguished by an extensive range of over 1,000 primary cell types and nearly 1,000 validated cell lines, supported by more than 2,000 types of optimized complete growth media beyond standard media. These products are meticulously formulated to ensure high cell viability and consistent growth, with each batch undergoing rigorous quality control, including STR profiling and mycoplasma testing.

Kohjin Bio is a Japanese biotechnology company specializing in serum-free cell culture media and regenerative medicine products, with a particularly strong focus on NK (natural killer) cell research and immunotherapy applications. The company is well known for its KBM series media, such as KBM501 and KBM502, which are designed for activation and expansion of human NK cells for ex vivo cell therapy workflows. Kohjin Bio’s NK-cell culture systems are widely used in cancer immunotherapy research, adoptive NK cell expansion, and clinical-grade cell processing because they are xeno-free, GMP-oriented, and optimized for high NK-cell proliferation and activity. Their products are commonly applied in academic institutes, hospitals, and cell therapy companies across Asia for developing NK-cell-based immunotherapies and immune cell manufacturing platforms.

Cell Patagonia is an Argentina-based biotechnology manufacturer specializing in animal-derived sera and blood products for cell culture applications, particularly fetal bovine serum (FBS) used in research, bioprocessing, and cell therapy workflows. The company emphasizes sourcing serum from Argentine-origin animals collected under SENASA-approved quality systems, with traceable and sanitary-certified livestock. Cell Patagonia focuses on producing high-quality serum with strong consistency, low contamination risk, and suitability for sensitive mammalian cell culture applications. Their serum products are positioned for laboratories requiring reliable growth support for adherent and suspension cells, while benefiting from Argentina’s recognized BSE-free status certified by international health authorities

AddexBio is a global biotechnology provider specializing in validated, high-quality cellular research tools. Their cell line portfolio and related services are designed to support academic, pharmaceutical, and biotechnology research

The JCRB Cell Bank (Japanese Collection of Research Bioresources) is a premier global repository offering over 1,600 human and animal cell lines for biomedical and pharmaceutical research. Their catalog features diverse cancer lines, primary cells, and genetically modified cells, extensively validated for strict quality control.